3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
25 25 0 1 0 0 0 0 0999 V2000
-1.2303 0.7131 -0.2999 N 0 0 1 0 0 0 0 0 0 0 0 0
3.6783 0.1051 -0.2106 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0830 0.0418 0.3265 C 0 0 1 0 0 0 0 0 0 0 0 0
-0.3620 -1.4362 0.0448 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8720 -1.5323 -0.1440 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3874 -0.1156 0.0466 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2599 0.4820 -0.2423 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4072 2.0901 0.1456 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4036 -0.3480 0.3331 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0957 0.1994 1.4146 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.0303 -2.0696 0.8750 H 0 0 0 0 0 0 0 0 0 0 0 0
0.1334 -1.7897 -0.8676 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.0968 -1.8938 -1.1544 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.3278 -2.2264 0.5695 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.2483 0.0889 -0.5977 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.6915 0.0292 1.0914 H 0 0 0 0 0 0 0 0 0 0 0 0
1.4301 1.5418 -0.0149 H 0 0 0 0 0 0 0 0 0 0 0 0
1.2529 0.3924 -1.3371 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.3028 2.5249 -0.3123 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.5643 2.7143 -0.1675 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.5083 2.1677 1.2341 H 0 0 0 0 0 0 0 0 0 0 0 0
2.2923 -1.4096 0.0939 H 0 0 0 0 0 0 0 0 0 0 0 0
2.4295 -0.2581 1.4245 H 0 0 0 0 0 0 0 0 0 0 0 0
3.8086 1.0941 -0.0005 H 0 0 0 0 0 0 0 0 0 0 0 0
3.6614 0.0351 -1.2274 H 0 0 0 0 0 0 0 0 0 0 0 0
1 3 1 0 0 0 0
1 6 1 0 0 0 0
1 8 1 0 0 0 0
2 9 1 0 0 0 0
2 24 1 0 0 0 0
2 25 1 0 0 0 0
3 4 1 0 0 0 0
3 7 1 0 0 0 0
3 10 1 0 0 0 0
4 5 1 0 0 0 0
4 11 1 0 0 0 0
4 12 1 0 0 0 0
5 6 1 0 0 0 0
5 13 1 0 0 0 0
5 14 1 0 0 0 0
6 15 1 0 0 0 0
6 16 1 0 0 0 0
7 9 1 0 0 0 0
7 17 1 0 0 0 0
7 18 1 0 0 0 0
8 19 1 0 0 0 0
8 20 1 0 0 0 0
8 21 1 0 0 0 0
9 22 1 0 0 0 0
9 23 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
2-(1-methylpyrrolidin-2-yl)ethanamine
4.2 InChl
InChI=1S/C7H16N2/c1-9-6-2-3-7(9)4-5-8/h7H,2-6,8H2,1H3
4.3 InChlKey
PNHGJPJOMCXSKN-UHFFFAOYSA-N
4.4 Canonical SMILES
CN1CCCC1CCN
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病